poisar

Stock

Telomir Pharmaceuticals, Inc. TELO

$1.19+0.85%

Overview

TELO market data

Price History

TELO price chart · 3M
O
1.19
H
1.19
L
1.19
C
1.19
Vol
227.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$1.19
Previous Close
$1.18
Day High
$1.19
Day Low
$1.19
52 Week High
$1.48
52 Week Low
$0.90
7 Day Return
+4.39%
30 Day Return
+6.25%
90 Day Return
-8.11%
1 Year Return
-16.20%
Daily Notional Volume
$270.1
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.33
Diluted earnings per share over the trailing twelve months.
Beta
-0.22
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.89 – $2.09
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $72.2M · P/B 7.73.

Company News

4 captured
Telomir Pharmaceuticals Publishes Peer-Reviewed Preclinical Data Of Telomir-ZnBenzinga · Aug 10, 2026, 12:04 PM
8-K filing — Telomir Pharmaceuticals, Inc. (TELO)SEC EDGAR · Aug 10, 2026, 12:00 PM
Telomir Pharmaceuticals Publishes Peer-Reviewed Preclinical Data In Biomedicine & Pharmacotherapy Titled "Telomir-Zn Restores Glucose Homeostasis and Reduces Insulin Resistance in a Diet-Induced Zebrafish Model of Type 2 Diabetes"Benzinga · Jun 15, 2026, 12:10 PM
Telomir Pharmaceuticals Appoints Andriy Mushak As Fractional CFO Following Departure Of CFO Alan Weichselbaum, Effective June 6, 2026Benzinga · Jun 8, 2026, 9:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Telomir Pharmaceuticals, Inc. (TELO) stock — price, valuation & news | Poisar